Andrew C. Karaplis

机构：Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University · ORCID：0000-0002-1595-8161

发表论文 160 篇 · 总被引 14300 次 · h-index 55

代表论文

• Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis (2017 · New England Journal of Medicine · 被引 1539)
• Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. (2014 · PubMed · 被引 139)
• Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone (2013 · Journal of Bone and Mineral Research · 被引 88)
• Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D (2016 · Journal of the American Society of Nephrology · 被引 77)
• CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders (2016 · Journal of Clinical Investigation · 被引 63)
• Neither Absence Nor Excess of FGF23 Disturbs Murine Fetal-Placental Phosphorus Homeostasis or Prenatal Skeletal Development and Mineralization (2014 · Endocrinology · 被引 50)